Yeah I get what you're saying with regards to corp
Post# of 148300
What I was saying was that in principle our press is free to the degree that they can report on whatever they want without the constraints imposed by an authoritarian or dictatorial regime like in other countries.
So the idea is that with consistent, outstanding results Leronlimab will rise to the forefront of public awareness with the help of media that doesn't have the aforementioned constraints imposed on it. And yes I'm sure there are/will be corporate motivations behind Leronlimab's promotion. But as of yet, it seems like only opposing forces have been in play. I'm not really seeing any the others you've mentioned promote CYDY to further their interests.